● Needs a look
Creatinine rose by 2.1 mg/dL within 21 hours during this stay (peak 3.9 mg/dL); the note doesn't mention a change in kidney function.
The note unsigned draft · Thu Nov 12, 2026 11:00 AM
Hospital day 2 progress note.
S: Admitted with cellulitis of the left leg. Received IV contrast for CT yesterday.
O: BP 142/84. Erythema receding from the marked border.
A/P:
1. Cellulitis: continue cefazolin.
2. CKD 3b: renally dose medications.
3. Type 2 diabetes: basal insulin, sliding scale.
Threshold: filtering rate below 60 on two results at least 90 days apart, none of 60 or more between them.
Other measurements checked against published definitions
Each definition is a draft pending clinical and coding review unless marked reviewed. You decide what the note says.
● Needs a lookLow glucose valuesDraft · pending review
Glucose 62 mg/dL on 2026-11-12 06:00 meets the published definition's criteria for the category “level 1 (glucose 54 to below 70 mg/dL)” (ada2026_hypoglycaemia@1.0). The note doesn't mention this.
Published bodies disagree on these thresholds; another definition may give a different answer.
6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes—2026
ada2026_hypoglycaemia@1.0
Level 1: Glucose <70 mg/dL (<3.9 mmol/L) and ≥54 mg/dL (≥3.0 mmol/L). Level 2: Glucose <54 mg/dL (<3.0 mmol/L). Level 3: A severe event characterized by altered mental and/or physical status requiring assistance for treatment of hypoglycemia
American Diabetes Association Professional Practice Committee · edition 2026 (Diabetes Care 2026;49 Suppl 1) · Table 6.4 Classification of hypoglycemia · opened 2026-11-14
· source
Threshold for this category (ada2026_hypoglycaemia@1.0): glucose ≥ 54 mg/dL and glucose < 70 mg/dL.
Draft definition: pending clinical and coding review.
Show all (6)
3 more, grouped by what was measured. At most three are shown above at once.
Sodium and potassium✓ Agrees
✓ AgreesPotassiumDraft · pending review
Potassium 5.3 mmol/L on 2026-11-12 07:00: in the category “below 5.5 mmol/L” of ukka2026_hyperkalaemia@1.0; the note doesn't mention this. Nothing to review.
Published bodies disagree on these thresholds; another definition may give a different answer.
Clinical Practice Guidelines: Treatment of Acute Hyperkalaemia in Adults
ukka2026_hyperkalaemia@1.0
It is further classified by severity into mild (5.5-5.9 mmol/l), moderate (6.0-6.4 mmol/l) or severe (≥ 6.5 mmol/l).
UK Kidney Association · edition updated July 2026 · Introduction, document page 9 (PDF page 10) · opened 2026-11-14
· source
Categories that count (ukka2026_hyperkalaemia@1.0): 'severe' band (6.5 mmol/L or more) (potassium ≥ 6.5 mmol/L); 'moderate' band (6.0 to 6.4 mmol/L) (potassium ≥ 6 mmol/L and potassium < 6.5 mmol/L); 'mild' band (5.5 to 5.9 mmol/L) (potassium ≥ 5.5 mmol/L and potassium < 6 mmol/L).
Draft definition: pending clinical and coding review.
Glucose and HbA1c✓ Agrees2
✓ AgreesGlucose and HbA1cDraft · pending review
The note says diabetes, and HbA1c 8.2 % on 2026-09-12 09:00 meets the published definition's criteria for the category “two results at or above the diagnostic thresholds” (ada2026_diabetes@1.0).
2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026
ada2026_diabetes@1.0
Table 2.1: A1C ≥6.5% (≥48 mmol/mol); FPG ≥126 mg/dL (≥7.0 mmol/L); 2-h PG ≥200 mg/dL (≥11.1 mmol/L) during OGTT; random plasma glucose ≥200 mg/dL (≥11.1 mmol/L) with classic symptoms of hyperglycemia or hyperglycemic crisis. In the absence of unequivocal hyperglycemia, diagnosis requires two abnormal results from different tests ... or the same test at two different time points.
American Diabetes Association Professional Practice Committee · edition 2026 (Diabetes Care 2026;49 Suppl 1:S27-S49, doi:10.2337/dc26-S002) · Table 2.1 Criteria for the diagnosis of diabetes in nonpregnant individuals · opened 2026-11-14
· source
Threshold for this category (ada2026_diabetes@1.0): number of qualifying results ≥ 2.
Draft definition: pending clinical and coding review.
✓ AgreesGlucose and HbA1c (intermediate range)Draft · pending review
HbA1c 8.2 % on 2026-09-12 09:00: in the category “a result in the higher (diagnostic) range” of ada2026_prediabetes@1.0; the note doesn't mention this. Nothing to review.
Published bodies disagree on these thresholds; another definition may give a different answer.
2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026
ada2026_prediabetes@1.0
A1C 5.7–6.4% (39–47 mmol/mol); FPG 100 mg/dL (5.6 mmol/L) to 125 mg/dL (6.9 mmol/L) (IFG); 2-h PG during 75-g OGTT 140 mg/dL (7.8 mmol/L) to 199 mg/dL (11.0 mmol/L) (IGT)
American Diabetes Association Professional Practice Committee · edition 2026 (Diabetes Care 2026;49 Suppl 1:S27-S49) · Table 2.2 Criteria defining prediabetes in nonpregnant individuals · opened 2026-11-14
· source
Categories that count (ada2026_prediabetes@1.0): intermediate range (HbA1c 5.7 to 6.4%, fasting glucose 100 to 125 mg/dL, or 2-hour glucose 140 to 199 mg/dL) (HbA1c ≥ 5.7 % and HbA1c < 6.5 % or fasting glucose ≥ 100 mg/dL and fasting glucose < 126 mg/dL or 2-hour glucose ≥ 140 mg/dL and 2-hour glucose < 200 mg/dL).
Draft definition: pending clinical and coding review.
Mode: measurements only (no diagnosis is named).
The check runs the same way on clinician-typed and AI-drafted notes (as declared by the source system).
✓eGFR: Note and criteria agreecriteria met under 2 of 2 eGFR equations (2021 race-free, 2009)
eGFR 39.3 on 2026-08-03 (lab row L-0036) and eGFR 40.6 on 2026-04-25 (lab row L-0035), 100 days apart, no value >= 60 between. KDIGO persistence: met. Persistent GFR category G3b (the range both values meet). Note: the kidney-function statement (quoted below) agrees with the persistent GFR category.
From the draft note: CKD 3b
Both directions
What the labs show that the note doesn't say
✓ Criteria met; the note has a statement
What the note says that the labs don't support
✓ Statement present; criteria met
✗not met:
Urine ACR >= 30 mg/g on two values at least 90 days apart (needed only when eGFR >= 60) (kdigo_ckd_2024@1.1) no urine ACR on file
✓met:
Latest creatinine below 1.5x the lowest value in the previous 365 days (otherwise: possible acute change; repeat needed) (kdigo_ckd_2024@1.1) 1.8 / 1.75 = 1.03x Rows: L-0035, L-0036
✓met:
No condition on record that makes the estimating equation unreliable (maintenance dialysis, kidney transplant, pregnancy, limb amputation or another extreme of muscle mass) (kidney_exclusions@1.0) none on record for this encounter date
✓met:
Two eGFR < 60 at least 90 days apart, none >= 60 between (2009 eGFR equation) (kdigo_ckd_2024@1.1) pair L-0035 (37.8, 2026-04-25) and L-0036 (36.5, 2026-08-03), 100 days apart; persistent category G3b (the range both values meet) Rows: L-0035, L-0036
✓met:
Two eGFR < 60 at least 90 days apart, none >= 60 between (2021 eGFR equation) (kdigo_ckd_2024@1.1) pair L-0035 (40.6, 2026-04-25) and L-0036 (39.3, 2026-08-03), 100 days apart; persistent category G3b (the range both values meet) Rows: L-0035, L-0036
✓met:
Values used are steady-state (local convention: values from an admission meeting the creatinine-change criteria are excluded) (kdigo_ckd_2024@1.1) excluded L-0037, L-0038 Rows: L-0037, L-0038
↑Creatinine change: Labs meet the criteria; nothing documented
Starting value 1.775 mg/dL
KDIGO stage at admission 0
KDIGO stage at peak 2
Same chart, four starting values
Starting value
mg/dL
Stage at admission
Stage at peak
Lowest value in the 365 days before admission
1.75
0
2
Most recent outpatient value 7-365 days before admission
1.8
0
2
Median of values in the 365 days before admission (selected)
1.775
0
2
Back-calculated from eGFR 75 (2021 equation, age and sex at admission)
1.049
1
3
Creatinine 1.8 mg/dL at admission (lab row L-0037), peak 3.9 mg/dL (lab row L-0038). KDIGO creatinine criterion met: criteria met under 1 of 4 baselines at admission; 4 of 4 at peak. Urine-output criterion not evaluated (no structured source). Note: no statement about an acute kidney change found.
Both directions
What the labs show that the note doesn't say
⚑ Criteria met; no statement in the note
What the note says that the labs don't support
✓ No statement in the note
✓met:
Creatinine rise >= 0.3 mg/dL within 48 hours (kdigo_aki_2012@1.1) L-0037 -> L-0038: +2.1 mg/dL in 21.0 h Rows: L-0037, L-0038
✓met:
No condition on record that makes the creatinine-change criteria unreliable (maintenance dialysis, kidney transplant, pregnancy) (kidney_exclusions@1.0) none on record for this encounter date
✓met:
A creatinine value before admission is available (needed before a statement can be called not supported) (kdigo_aki_2012@1.1) available Rows: L-0035, L-0036
✓met:
Creatinine >= 1.5x baseline (back-calculated from egfr 75 (2021 equation, age and sex at admission)) (kdigo_aki_2012@1.1) baseline 1.049 mg/dL; admission stage 1, peak stage 3 (never used alone) Rows: L-0037, L-0038
✓met:
Creatinine >= 1.5x baseline (most recent outpatient value 7-365 days before admission) (kdigo_aki_2012@1.1) baseline 1.8 mg/dL; admission stage 0, peak stage 2 Rows: L-0036, L-0037, L-0038
✓met:
Creatinine >= 1.5x baseline (lowest value in the 365 days before admission) (kdigo_aki_2012@1.1) baseline 1.75 mg/dL; admission stage 0, peak stage 2 Rows: L-0035, L-0037, L-0038
✓met:
Creatinine >= 1.5x baseline (median of values in the 365 days before admission) (kdigo_aki_2012@1.1) baseline 1.775 mg/dL; admission stage 0, peak stage 2 Rows: L-0035, L-0036, L-0037, L-0038
✗not met:
Reverse comparison: admission or peak creatinine >= 1.5x the lowest value in the following 7 days (kdigo_aki_2012@1.1) L-0037 1.8 mg/dL vs L-0038 3.9 mg/dL: 0.46x Rows: L-0037, L-0038
Try one creatinine value
One value is never a confirmed stage: the persistence rule needs a repeat at least 90 days later.